Our data demonstrate that NID2 overexpression in male mice promotes hepatic steatosis, as evidenced by increased triglyceride, NEFA levels, and ORO staining of liver frozen sections, as well as increased plasma triglycerides. Here, NID2 is linked to Hepatic steatosis.